Evidence map›Paper›PMID 34966950›Full record

ArticleDiabetologia2022

Longitudinal changes in glucose during pregnancy in women with gestational diabetes risk factors.

Milana A Bochkur Dratver, Juliana Arenas, Tanayott Thaweethai, Chu Yu, Kaitlyn James, Emily A Rosenberg, Michael J Callahan, Melody Cayford, Jessica S Tangren, Sarah N Bernstein and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Carbohydrate Intake and Oral Glucose Tolerance Test Results in the Postpartum Period.The Journal of clinical endocrinology and metabolism · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Milana A Bochkur DratverHarvard Medical School, Boston, MA, USA.
Juliana ArenasDiabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
Tanayott ThaweethaiHarvard Medical School, Boston, MA, USA.ORCID 0000-0003-0613-4176
Chu YuBiostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Kaitlyn JamesHarvard Medical School, Boston, MA, USA.
Emily A RosenbergHarvard Medical School, Boston, MA, USA.
Michael J CallahanDiabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
Melody CayfordDiabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
Jessica S TangrenHarvard Medical School, Boston, MA, USA.
Sarah N BernsteinHarvard Medical School, Boston, MA, USA.
Marie France HivertHarvard Medical School, Boston, MA, USA.
Ravi ThadhaniHarvard Medical School, Boston, MA, USA.
Camille E PoweHarvard Medical School, Boston, MA, USA. camille.powe@mgh.harvard.edu.ORCID 0000-0002-7060-7778
Harvard University · USMassachusetts General Hospital · USBrigham and Women's Hospital · USBroad Institute · USUniversity of Massachusetts Chan Medical School · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
TRAINING GRANT IN ACADEMIC ENDOCRINOLOGYT32DK007529 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI Ursula B. Kaiser, Anand Vaidya · 1986 to 2026
$6.3M
Impact of insulin-like growth factors and binding proteins on gestational diabetes and fetal growthR01HD094150 · NICHD · HARVARD PILGRIM HEALTH CARE, INC. · PI Marie-France Hivert, Camille Elise Powe · 2018 to 2026
$4.2M
Elucidating Determinants of Gestational Beta-Cell Adaptation and FailureK23DK113218 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI POWE, CAMILLE ELISE · 2017 to 2021
$1.0M
Renal Circulatory Adaptation in Healthy and Complicated PregnanciesK23DK120874 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI TANGREN, JESSICA SHEEHAN · 2019 to 2023
$918k
Uncovering the Role of Dietary Fat and Protein in Glycemic Physiology in Pregnancy and in Gestational DiabetesF32DK126343 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSENBERG, EMILY · 2021 to 2022
$164k
NCATS NIH HHS UL1 TR000170NCATS NIH HHS UL1 TR001102NICHD NIH HHS R01 HD094150NIDDK NIH HHS F32 DK126343NIDDK NIH HHS K23 DK113218NIDDK NIH HHS K23 DK120874NIDDK NIH HHS T32 DK007529
6 · The paper itself

Abstract

aims/hypothesisDespite recommendations to screen women with diabetes risk factors for hyperglycaemia in the first trimester, criteria for normal glucose values in early pregnancy have not been firmly established. We aimed to compare glucose levels in early pregnancy with those later in gestation and outside of pregnancy in women with diabetes risk factors.

methodsIn pregnant women (N = 123) followed longitudinally through the postpartum period, and a separate cohort of non-pregnant women (N = 65), we performed 75 g oral glucose tolerance tests. All participants had one or more risk factors for diabetes. Using linear regression, we tested for differences in glucose levels between non-pregnant and pregnant women at early (7-15 weeks) and mid-late (24-32 weeks) gestation as well as postpartum, with adjustment for maternal age, parity, marital status and BMI. In a longitudinal analysis using mixed-effects models, we tested for differences in glucose levels across early and mid-late pregnancy compared with postpartum. Differences are expressed as β (95% CI).

resultsFasting glucose was lower in pregnant compared with non-pregnant women by 0.34 (0.18, 0.51) mmol/l (p < 0.0001) in early pregnancy and by 0.45 (0.29, 0.61) mmol/l (p < 0.0001) in mid-late pregnancy. In longitudinal models, fasting glucose was lower by 0.13 (0.04, 0.21) mmol/l (p = 0.003) in early pregnancy and by 0.16 (0.08, 0.25) mmol/l (p = 0.0003) in mid-late pregnancy compared with the same women postpartum. Early pregnancy post-load glucose levels did not differ from those in non-pregnant women or the same women postpartum. In mid-late pregnancy, compared with non-pregnant women, elevations in 1 h post-load glucose level (0.60 [-0.12, 1.33] mmol/l, p = 0.10) and 2 h post-load glucose (0.49 [-0.21, 1.19] mmol/l, p = 0.17) were not statistically significant. However, in longitudinal analyses, 1 h and 2 h post-load glucose levels were higher in mid-late pregnancy (by 0.78 [0.35, 1.21] mmol/l, p = 0.0004, and 0.67 [0.30, 1.04] mmol/l, p = 0.0005, respectively) when compared with postpartum. CONCLUSIONS/

interpretationIn women with diabetes risk factors, fasting glucose declines in the first trimester. Post-load glucose increases later in pregnancy. These findings may inform criteria for diagnosing hyperglycaemia early in pregnancy.

Indexed as

Diabetes, GestationalBlood GlucoseFemaleGlucoseHumansParityPregnancyRisk FactorsBlood GlucoseGlucoseGestational diabetesGlucose levelsOral glucose tolerance testingPregnancy

Identifiers

PMID34966950
PMCPMC8904203
OpenAlexW4200626035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.